GL1X · GenesisL1 explorer

MolNFT v1 · #162174 · protein

Cereblon isoform 4 from magnetospirillum gryphiswaldense in complex with compound 7F

6R13: “Cereblon isoform 4 from magnetospirillum gryphiswaldense in complex with compound 7F”. X-ray diffraction, 5 ligands (EF2, JOK, ZN), 3 pockets (best druggability 0.63). MolNFT v1 #162174 on GenesisL1: 3D structure, binding sites and…

PDB
6R13
Type
protein
Length
288 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cereblon isoform 4
UniProt
A4TVL0
Ligands
EF2, JOK, ZN, PO4, CL
Pockets
3 · best druggability 0.63

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACereblon isoform 4protein1088% helix, 48% strandA4TVL0
BCereblon isoform 4protein1059% helix, 50% strandA4TVL0
CCereblon isoform 4protein750% helix, 51% strandA4TVL0

Ligands and binding sites

  • EF2 · S-Thalidomide · ligand · chains A
  • JOK · ~{N}-[(3~{S})-2,5-bis(oxidanylidene)pyrrolidin-3-yl]-3-phenyl-propanamide · ligand · chains B
  • ZN · Zinc ion · metal · 3 copies · chains A, B, C
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13940.630.7753empty
2790.440.8020empty
3520.380.8014EF2

Interfaces

2 interfaces between chains.

  • A–B · 621 Ų buried · 8 hydrogen bonds · protein-protein
  • A–C · 439 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 6R13 · Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7f · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.